watchgot.online


BIO TECHNE STOCK FORECAST

Analyst Forecast. According to 9 analysts, the average rating for TECH stock is "Buy." The month stock price forecast is $, which is an increase of. If you are looking for stocks with good return, Bio-Techne Corp stock can be a bad, high-risk 1-year investment option. Bio-Techne Corp real time quote is equal. Over the last 12 months, its price rose by percent. Looking ahead, we forecast Bio Techne to be priced at by the end of this quarter and at in. Is Bio-Techne Corp stock A Buy? Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a. Get Bio-Techne Corp (TECH:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

(NASDAQ: TECH) Bio Techne stock price per share is $ today (as of Mar 11, ). What is Bio Techne's Market Cap. Bio-Techne Corporation (watchgot.online): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Bio-Techne Corporation | Nasdaq. Reported EPS is $ EPS, expectations were $ Bio-Techne Corporation isn't one of the 30 most popular stocks among hedge funds at the end of the third. Bio-Techne Corp Analysis ; This Double-Discounted % Dividend Has a Big Edge in · Jan 11, ; Bargain-Hunt The Selloff The Smart Way With These 9%+. Stocks were mixed on Thursday morning as investors focused on new inflation data. The Labor Department said that its consumer price index rose % on a month-. Get the latest Bio-Techne (TECH) stock forecast for tomorrow and next week. Stay ahead of the game with our Bio-Techne stock price prediction for and. Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. Based on the Bio-Techne Corp stock forecast from 6 analysts, the average analyst target price for Bio-Techne Corp is USD over the next 12 months. Bio. Bio-Techne Corporation Stock Forecast ; Market Cap, N/A ; ATR14, € (%) ; P/E Ratio, ; Beta, ; Dividend Rate, % (). Based on analysts offering 12 month price targets for TECH in the last 3 months. The average price target is $ with a high estimate of $95 and a low. Wall Street analysts forecast TECH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TECH is.

on a frequent basis to provide recommendations along with target share price. 19 analysts offering month price forecasts for Bio-techne Corp. (TECH) have a. According to the current price, Bio-Techne is % away from the week high. What are analysts forecasts for Bio-Techne stock? The 26 analysts offering. Future price of the stock is predicted at $ (%) after a year according to our prediction system. This means that if you. Is Bio-Techne Stock Undervalued? The current Bio-Techne [TECH] share price is $ The Score for TECH is 35, which is 30% below its historic median score of. Earnings for Bio-Techne are expected to grow by % in the coming year, from $ to $ per share. Price to Earnings Ratio vs. the Market. The P/E ratio. Based on short-term price targets offered by 11 analysts, the average price target for Techne comes to $ The forecasts range from a low of $ to a. The 8 analysts with month price forecasts for Bio-Techne stock have an average target of , with a low estimate of 65 and a high estimate of The. The average one-year price target for Bio-Techne Corp is $ The forecasts range from a low of $ to a high of $ A stock's price target is. Price History & Performance ; Current Share Price, US$ ; 52 Week High, US$ ; 52 Week Low, US$ ; Beta,

none raised and none lowered their forecast. For the fiscal year ending Jun , the consensus EPS* forecast has remained the same over the past week at On average, Wall Street analysts predict that Bio Techne's share price could reach $ by Feb 2, The average Bio Techne stock price prediction. Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It. TECH's current price target is $ Learn why top analysts are making this stock forecast for Bio-Techne at MarketBeat. Discover Bio-Techne's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers.

Buy Bio-techne Corp. Shares from India at $ (0 Commission) today. Start investing in Bio-techne Corp. stocks from India now with fractional investing. The average one-year price target for Bio-Techne Corporation is $ The forecasts range from a low of $ to a high of $ A stock's price target is. Bio-Techne Stock Forecast, TE1 stock price prediction. Price target in 14 days: EUR. The best long-term & short-term Bio-Techne share price prognosis. Get Bio-Techne Corp (watchgot.online) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. One year price forecast for Bio-Techne Corp has a max estimate of USD and a min estimate of USD. Does Bio-Techne Corp release reports?

larvalabs | pattern recognition software for trading

11 12 13 14 15


Copyright 2016-2024 Privice Policy Contacts SiteMap RSS